Pathophysiological characteristics of non-alcoholic steatohepatitis-like changes in cholesterol-loaded type 2 diabetic rats

Physiological Research
Y ToriniwaTakeshi Ohta

Abstract

Spontaneously Diabetic Torii (SDT) fatty rats, a new obese diabetic model, reportedly presented with features of non-alcoholic steatohepatitis (NASH) after 32 weeks of age. We tried to accelerate the onset of NASH in SDT fatty rats using dietary cholesterol loading and noticed changes in the blood choline level which is expected to be a NASH biomarker. Body weight and biochemical parameters were measured from 8 to 24 weeks of age. At 16, 20, 24 weeks, pathophysiological analysis of the livers were performed. Hepatic lipids, lipid peroxides, and the expression of mRNA related to triglyceride (TG) synthesis, inflammation, and fibrosis were evaluated at 24 weeks. Hepatic fibrosis was observed in SDT fatty rats fed cholesterol-enriched diets (SDT fatty-Cho) from 16 weeks. Furthermore, hepatic lipids and lipid peroxide were significantly higher in SDT fatty-Cho than SDT fatty rats fed normal diets at 24 weeks. Hepatic mRNA expression related to TG secretion decreased in SDT fatty-Cho, and the mRNA expression related to inflammation and fibrosis increased in SDT fatty-Cho at 24 weeks. Furthermore, SDT fatty-Cho presented with increased plasma choline, similar to human NASH. There were no significant changes in the effects of feeding ...Continue Reading

References

Dec 14, 1995·Biochemical and Biophysical Research Communications·S TakekoshiK Watanabe
Oct 4, 2005·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Anna Mae Diehl
Jan 13, 2006·Biochemical and Biophysical Research Communications·Mònica TousJorge Joven
Sep 5, 2006·Cell Metabolism·Montserrat MaríCarmen García-Ruiz
Aug 7, 2007·Molecular Cell·Anja Jaeschke, Roger J Davis
Feb 29, 2008·Journal of Hepatology·Nimantha Mark Wilfred de Alwis, Christopher Paul Day
Apr 15, 2008·Current Opinion in Gastroenterology·Victoria GreenfieldArun J Sanyal
Jul 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kristiaan WoutersMarten H Hofker
Oct 22, 2008·World Journal of Gastroenterology : WJG·Tatsuhiro TsujimotoHiroshi Fukui
Nov 27, 2008·World Journal of Gastroenterology : WJG·Hideto KawarataniHiroshi Fukui
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Lars P BechmannAli Canbay
Mar 14, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shahid M MalikJawad Ahmad
Nov 26, 2009·World Journal of Gastroenterology : WJG·Tatsuhiro TsujimotoHiroshi Fukui
Dec 4, 2010·International Journal of Cancer. Journal International Du Cancer·Judith ErtleAli Canbay
Jan 4, 2012·Mayo Clinic Proceedings·Ju Dong YangW Ray Kim
May 10, 2012·Gut and Liver·Geoffrey C FarrellShivrakumar Chitturi
Jul 12, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kento ImajoAtsushi Nakajima
Dec 5, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kentaro ToriumiSusumu Takekoshi
Mar 19, 2013·Journal of Gastroenterology·Kento ImajoAtsushi Nakajima
Nov 22, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Samar H IbrahimRohit Kohli
Apr 29, 2014·Experimental Animals·Yoshiaki KatsudaTakahisa Yamada
Aug 21, 2015·World Journal of Gastroenterology : WJG·Yukihito IshiiTakeshi Ohta
Sep 19, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Bing-Hang LiJian-Gao Fan
May 17, 2017·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Evelyn ZöhrerValerio Nobili

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.